🇺🇸 FDA
Patent

US 9182412

Borrelia diagnostics and screening methods

granted A61PA61P31/04A61P37/04

Quick answer

US patent 9182412 (Borrelia diagnostics and screening methods) held by The Regents of the University of California expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P31/04, A61P37/04